drugset / Trial / NCT00553553
Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
The patient population requiring hepatic resection can demonstrate an unpredictable risk of exhibiting peri-operative coagulopathy resulting either from the pre-operative hepatic pathophysiology or volume of parenchymal resection. Choice of analgesia can be severely limited. Currently, the most commonly described use of combined remifentanil infusion and intrathecal morphine has been in fast-track cardiac surgery. To date, there are no published data describing its use in the context of major hepatobiliary where the investigators predict it may provide adequate analgesia with a lower rate of adverse effects over the first 24 hours after surgery.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-05
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 10 ug/kg | Intravenous |
| Subject | Morphine | Other / unclassified | 0.25 mg/kg | Intravenous |
| Subject | Remifentanil | Small molecule | 0.1 ug/kg | Intravenous |
| Subject | Remifentanil | Small molecule | 0.25 ug/kg | Intravenous |